U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
• 1.7 List of Secondary Sources
• 1.8 Objectives
  • 1.8.1 Objective 1
  • 1.8.2 Objective 2
  • 1.8.3 Objective 3
  • 1.8.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Penetration & Growth Prospect Mapping
• 2.3 Market Dynamics
  • 2.3.1 Market driver analysis
    • 2.3.1.1 Increasing geriatric population
    • 2.3.1.2 Rising prevalence of chronic disorders
    • 2.3.1.3 Rapid technological advancements
    • 2.3.1.4 Growing incidence of hospital-acquired infections
    • 2.3.1.5 Home healthcare as a cost-effective alternative
  • 2.3.2 Market restrain analysis
    • 2.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
  • 2.3.3 Impact Of The 21st Century Cures Act And Projections For The Impact Of The Bipartisan Budget Act Of 2018.
  • 2.3.4 Trends For Home Infusion For Medicare Part B And Medicare Part D
• 2.4 U.S. Home Infusion Therapy: Market Analysis Tools
  • 2.4.1 Industry analysis - Porter's
  • 2.4.2 PESTLE analysis
• 2.5 U.S Home Infusion Therapy- Company Market Share Analysis 2023
• 2.6 Major Deals & Strategic Alliances Analysis
• 2.7 Procedure cost analysis/breakdown
• 2.8 Technology Timeline
• 2.9 Regulatory Framework
• 2.10 Reimbursement framework

Chapter 3 U.S Home Infusion Therapy Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 3.1 Product Market Share Analysis, 2023 & 2030
• 3.2 U.S. Home Infusion Therapy Market, by Product, 2023 to 2030
• 3.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
  • 3.3.1 Infusion pumps
    • 3.3.1.1 Infusion Pumps Market, 2018 - 2030 (USD Million)
    • 3.3.1.2 Elastomeric Market, 2018 - 2030 (USD Million)
    • 3.3.1.3 Electromechanical Market, 2018 - 2030 (USD Million)
    • 3.3.1.4 Gravity Market, 2018 - 2030 (USD Million)
    • 3.3.1.5 Others Market, 2018 - 2030 (USD Million)
  • 3.3.2 Intravenous sets
  • 3.3.3 Intravenous Sets Market, 2018 - 2030 (USD Million)
  • 3.3.4 Gravity Sets Market, 2018 - 2030 (USD Million)
  • 3.3.5 Dedicated Sets Market, 2018 - 2030 (USD Million)
  • 3.3.6 IV Cannulas
    • 3.3.6.1 IV Cannulas Market, 2018 - 2030 (Usd Million)
  • 3.3.7 Needleless Connectors
    • 3.3.7.1 Needleless Connectors Market, 2018 - 2030 (USD Million)

Chapter 4 U.S. Home Infusion Therapy Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 4.1 Application Market Share Analysis, 2023 & 2030
• 4.2 U.S. Home Infusion Therapy Market, by Application, 2023 to 2030
• 4.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
  • 4.3.1 Anti-Infective
    • 4.3.1.1 Anti-infective market, 2018 - 2030 (USD Million)
  • 4.3.2 endocrinology
    • 4.3.2.1 ENDOCRINOLOGY MARKET, 2018 - 2030 (USD Million)
    • 4.3.2.2 Diabetes market, 2018 - 2030 (USD Million)
    • 4.3.2.3 Others market, 2018 - 2030 (USD Million)
  • 4.3.3 Hydration therapy
    • 4.3.3.1 hydration therapy market, 2018 - 2030 (USD Million)
    • 4.3.3.2 Athletes market, 2018 - 2030 (USD Million)
    • 4.3.3.3 Others market, 2018 - 2030 (USD Million)
  • 4.3.4 Chemotherapy
    • 4.3.4.1 CHEMOTHERAPY MARKET, 2018 - 2030 (USD Million)
  • 4.3.5 Enteral nutrition
    • 4.3.5.1 ENTERAL NUTRITION market, 2018 - 2030 (USD Million)
  • 4.3.6 Parenteral nutrition
    • 4.3.6.1 PARENTERAL NUTRITION market, 2018 - 2030 (USD Million)
  • 4.3.7 Specialty pharmaceuticals
    • 4.3.7.1 SPECIALTY PHARMACEUTICALS MARKET, 2018 - 2030 (USD Million)
  • 4.3.8 Others
    • 4.3.8.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Home Infusion Therapy Market: Country Market Analysis, By Product, 2018 - 2030 (USD Million)

• 5.1 Market Size, & Forecasts and Trend Analysis, 2023 to 2030
• 5.2 U.S.
  • 5.2.1 U.S. Home Infusion Therapy market, by product, 2018 - 2030 (USD Million)
  • 5.2.2 U.S. Home Infusion Therapy market, by Appliction, 2018 - 2030 (USD Million)

Chapter 6 Home Infusion Therapy Market - Competitive Analysis

• 6.1 Competitive Dashboard Analysis - Impact Analysis
  • 6.1.1 Recent Developments & Impact Analysis, By Key Market Participants
• 6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.2.1 List of key innovators
  • 6.2.2 List of market leader
  • 6.2.3 List of emerging players
• 6.3 Company market position analysis (Revenue, product portfolio, key serviceable industries, key alliances)
  • 6.3.1 By Revenue
• 6.4 Strategy Framework
• 6.5 Company Profiles
  • 6.5.1 B. Braun Melsungen AG
    • 6.5.1.1 Company overview
    • 6.5.1.2 Financial performance
    • 6.5.1.3 Product benchmarking
    • 6.5.1.4 Strategic initiatives
  • 6.5.2 Baxter
    • 6.5.2.1 Company overview
    • 6.5.2.2 Financial performance
    • 6.5.2.3 Product benchmarking
    • 6.5.2.4 Strategic initiatives
  • 6.5.3 Caesarea Medical Electronics
    • 6.5.3.1 Company overview
    • 6.5.3.2 Product benchmarking
    • 6.5.3.3 Strategic initiatives
  • 6.5.4 CareFusion Corporation
    • 6.5.4.1 Company overview
    • 6.5.4.2 Financial performance
    • 6.5.4.3 Product benchmarking
    • 6.5.4.4 Strategic initiatives
  • 6.5.5 Fresenius Kabi AG
    • 6.5.5.1 Company overview
    • 6.5.5.2 Financial performance
    • 6.5.5.3 Product benchmarking
    • 6.5.5.4 Strategic initiatives
  • 6.5.6 ICU Medical, Inc.
    • 6.5.6.1 Company overview
    • 6.5.6.2 Financial performance
    • 6.5.6.3 Product benchmarking
    • 6.5.6.4 Strategic initiatives
  • 6.5.7 JMS Co., Ltd.
    • 6.5.7.1 Company overview
    • 6.5.7.2 Financial performance
    • 6.5.7.3 Product benchmarking
  • 6.5.8 Smiths Medical
    • 6.5.8.1 Company overview
    • 6.5.8.2 Financial performance
    • 6.5.8.3 Product benchmarking
    • 6.5.8.4 Strategic initiatives
  • 6.5.9 Terumo Corporation
    • 6.5.9.1 Company overview
    • 6.5.9.2 Financial performance
    • 6.5.9.3 Product benchmarking
    • 6.5.9.4 Strategic initiatives
  • 6.5.10 Coram LLC
    • 6.5.10.1 Company overview
    • 6.5.10.2 Product benchmarking
  • 6.5.11 Option Care Enterprises, Inc.
    • 6.5.11.1 Company overview
    • 6.5.11.2 Financial performance
    • 6.5.11.3 Product benchmarking
    • 6.5.11.4 Strategic initiatives
  • 6.5.12 BioScrip, Inc.
    • 6.5.12.1 Company overview
    • 6.5.12.2 Financial performance
    • 6.5.12.3 Product benchmarking
    • 6.5.12.4 Strategic initiatives
  • 6.5.13 BriovaRx Infusion Services
    • 6.5.13.1 Company overview
    • 6.5.13.2 Financial performance
    • 6.5.13.3 Product benchmarking
    • 6.5.13.4 Strategic initiatives
  • 6.6.14 Paragon Healthcare, Inc.
    • 6.6.14.1 Company overview
    • 6.6.14.2 Financial performance
    • 6.6.14.3 Product benchmarking

List of Tables

• Table 1 List of secondary sources
• Table 2 U.S. Home Infusion Therapy market, leading market players per region
• Table 3 U.S. Home Infusion Therapy market, Regional Network Map
• Table 4 U.S. Home Infusion Therapy market, market differentiating factor

List of Figures

• Fig. 1 U.S. home infusion therapy market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Commodity flow analysis
• Fig. 9 Market outlook (2023)
• Fig. 10 Penetration & growth prospect mapping
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 U.S. population over 60 years by age, 1900 - 2050
• Fig. 13 Prevalence of chronic disease in the U.S.
• Fig. 14 Treatment cost by healthcare setting (Average cost per day in USD)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's five forces analysis
• Fig. 17 PESTLE analysis
• Fig. 18 U.S. Home Infusion Therapy market: Company market share analysis, 2023
• Fig. 19 U.S. Home Infusion Therapy market: Company market share analysis, 2023
• Fig. 20 U.S. Home Infusion Therapy Market: Product movement analysis
• Fig. 21 U.S. Home Infusion Therapy Market Product Outlook: Key takeaways
• Fig. 22 Infusion pumps market, 2018 - 2030 (USD Million)
• Fig. 23 Elastomeric market, 2018 - 2030 (USD Million)
• Fig. 24 Electromechanical market, 2018 - 2030 (USD Million)
• Fig. 25 Gravity market, 2018 - 2030 (USD Million)
• Fig. 26 Others market, 2018 - 2030 (USD Million)
• Fig. 27 Intravenous sets market, 2018 - 2030 (USD Million)
• Fig. 28 Intravenous sets market, 2018 - 2030 (USD Million)
• Fig. 29 Dedicated sets market, 2018 - 2030 (USD Million)
• Fig. 30 IV cannulas market, 2018 - 2030 (USD Million)
• Fig. 31 Needleless connectors market, 2018 - 2030 (USD Million)
• Fig. 32 U.S. home infusion therapy market: Application movement analysis
• Fig. 33 Home infusion therapy market application outlook: Key takeaways
• Fig. 34 Anti-infective market, 2018 - 2030 (USD Million)
• Fig. 35 Endocrinology market, 2018 - 2030 (USD Million)
• Fig. 36 Diabetes market, 2018 - 2030 (USD Million)
• Fig. 37 Others market, 2018 - 2030 (USD Million)
• Fig. 38 Hydration therapy market, 2018 - 2030 (USD Million)
• Fig. 39 Athletes market, 2018 - 2030 (USD Million)
• Fig. 40 Others market, 2018 - 2030 (USD Million)
• Fig. 41 Chemotherapy market, 2018 - 2030 (USD Million)
• Fig. 42 Enteral nutrition market, 2018 - 2030 (USD Million)
• Fig. 43 Parenteral nutrition market, 2018 - 2030 (USD Million)
• Fig. 44 Specialty pharmaceuticals market, 2018 - 2030 (USD Million)
• Fig. 45 Others market, 2018 - 2030 (USD Million)
• Fig. 46 U.S. Country Dynamics
• Fig. 47 Recent Developments & Impact Analysis
• Fig. 48 Strategy Framework